Interne link ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026 september 09, 2026 om 12:00 PM UTC
Interne link ProQR to Participate in Upcoming Investor Conferences in September 2026 september 02, 2026 om 12:00 PM UTC
Interne link ProQR Announces Second Quarter 2026 Operating and Financial Results augustus 13, 2026 om 11:00 AM UTC
Interne link ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement juni 25, 2026 om 10:35 AM UTC
Interne link ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform juni 25, 2026 om 10:25 AM UTC
Interne link ProQR Announces First Quarter 2026 Operating and Financial Results mei 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform mei 11, 2026 om 12:00 PM UTC
Interne link ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 mei 04, 2026 om 12:00 PM UTC
Interne link ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors april 30, 2026 om 12:00 PM UTC
Interne link ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event april 08, 2026 om 08:00 PM UTC
Interne link ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board april 08, 2026 om 12:00 PM UTC
Interne link ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 maart 25, 2026 om 12:00 PM UTC
Interne link ProQR Announces Year End 2025 Operating and Financial Results maart 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference maart 03, 2026 om 09:30 PM UTC
Interne link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook januari 08, 2026 om 01:00 PM UTC
Interne link ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital december 30, 2021 om 12:00 PM UTC
Interne link ProQR Announces First Patients Dosed in Phase 2/3 Pivotal Trials of QR-421a for USH2A Mediated Retinitis Pigmentosa december 16, 2021 om 12:00 PM UTC
Interne link ProQR Announces Upcoming Investor Conferences in November and December november 08, 2021 om 09:30 PM UTC
Interne link ProQR Announces Third Quarter 2021 Operating and Financial Results november 04, 2021 om 11:00 AM UTC
Interne link ProQR Appoints Theresa Heggie as Chief Commercial Officer oktober 04, 2021 om 12:00 PM UTC
Interne link ProQR Announces Conference Call to Discuss the Axiomer® RNA Editing Platform september 08, 2021 om 08:15 PM UTC
Interne link ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly september 08, 2021 om 08:01 PM UTC